Adjuvant Capital
Investments
30
Lead Investments
10
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.
Highlights
Focus Areas
Biotechnology
Health Care
Medical
Life Science
Biopharma
Investment Types
Convertible Note
Early Stage Venture
Late Stage Venture
Notable Investments
